Investor Type | Firm |
Investing | United States |
Eir Partners is a strategic partnership and investment firm that is solely focused on the dynamic global healthcare and technology marketplace. They have developed a model that emphasizes customized collaboration to accelerate disruption, innovation, and growth through strategic partnerships and direct investments. Eir Partners primarily invests in growth equity through control buyouts in companies operating in the healthcare technology, technology-enabled services, consumer retail, and other health-related sectors. Since their founding in 2015, headquartered in New York, they have expanded and also operate from Miami, Florida. Eir Partners harnesses its operational expertise combined with thematic sourcing efforts to improve the value creation process. The firm has engaged with notable industry players such as Apixio, Capta, GiftHealth, Helpware, ReviveHealth, and PharmaForceIQ, demonstrating a pattern of identifying and nurturing potential growth in various areas within the healthcare technology landscape. Their targeted stages of investment include growth equity through control buyouts, with equity check sizes ranging from $25 to $100 million. Their investment strategy is built around optimizing opportunity by employing a blend of EQ and IQ to increase activity and create actionable opportunities, thereby helping portfolio companies to achieve growth goals more rapidly and effectively than competitors. Additionally, Eir Partners works on elevating the status of entities within their portfolio by augmenting corporate and strategic development efforts, giving these companies a significant competitive advantage. The firm aims to tailor its investment approach for each opportunity to ensure alignment with partnered companies' goals. Their strategy includes direct platform investments as the sole or lead investor, as well as a dedicated co-investment model alongside private equity firms, venture capital entities, family offices, and strategic investors. In the context of a co-investment relationship, Eir typically takes on strategic and corporate development roles.